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Joubert	syndrome	(JBTS)	is	characterized	by	a	specific	brain	malformation	with	various	additional	pathologies.	It	
results	from	mutations	in	any	one	of	at	least	10	different	genes,	including	NPHP1,	which	encodes	nephrocystin-1.	
JBTS	has	been	linked	to	dysfunction	of	primary	cilia,	since	the	gene	products	known	to	be	associated	with	the	dis-
order	localize	to	this	evolutionarily	ancient	organelle.	Here	we	report	the	identification	of	a	disease	locus,	JBTS12,	
with	mutations	in	the	KIF7	gene,	an	ortholog	of	the	Drosophila	kinesin	Costal2,	in	a	consanguineous	JBTS	family	
and	subsequently	in	other	JBTS	patients.	Interestingly,	KIF7	is	a	known	regulator	of	Hedgehog	signaling	and	a	
putative	ciliary	motor	protein.	We	found	that	KIF7	co-precipitated	with	nephrocystin-1.	Further,	knockdown	of	
KIF7	expression	in	cell	lines	caused	defects	in	cilia	formation	and	induced	abnormal	centrosomal	duplication	
and	fragmentation	of	the	Golgi	network.	These	cellular	phenotypes	likely	resulted	from	abnormal	tubulin	acety-
lation	and	microtubular	dynamics.	Thus,	we	suggest	that	modified	microtubule	stability	and	growth	direction	
caused	by	loss	of	KIF7	function	may	be	an	underlying	disease	mechanism	contributing	to	JBTS.
Introduction
Joubert syndrome (JBTS) is a rare, mostly autosomal recessively 
inherited developmental disorder characterized by cerebellar hypo-
plasia, ataxia, psychomotor delay, and an altered respiratory pat-
tern in the neonatal period. Retinal degeneration, renal cysts, liver 
fibrosis, and skeletal involvement can be present. The hallmark of 
JBTS is a midbrain-hindbrain malformation, named “molar tooth 
sign” (MTS) because of its appearance on axial magnetic resonance 
imaging. The 10 genes implicated in JBTS, CEP290, TMEM67/
MKS3, RPGRIP1L, ARL13B, AHI1, NPHP1, CC2D2A, INPP5E, 
TMEM21, and OFD1, all play a role in the formation or function 
of sensory cilia (1). Primary cilia are essential for vertebrate devel-
opment, and mutations affecting this organelle underlie a large 
group of human malformation syndromes, the ciliopathies (2). 
Cilia are antenna-like protrusions on the cell surface, covered by 
the plasma membrane and containing a ring of 9 microtubule 
doublets. Studies in mutants with defective ciliogenesis revealed 
that cilia are essential for vertebrate Hedgehog (Hh) signaling, a 
pathway that is crucial for embryonic patterning, organogenesis, 
and tumor formation (3).
Most JBTS genes have been identified through linkage analy-
sis in consanguineous families. Using such an approach, we have 
mapped a novel JBTS locus, JBTS12, to chromosome 15q25.3–
q26.3 in an Egyptian family. One gene in that locus, KIF7 (Gen-
Bank NM_198525), represented a prime candidate for the novel 
JBTS subtype because of its assumed dual roles as a Sonic Hedge-
hog (Shh) pathway component and a ciliary motor protein (3). 
Here, we identify KIF7 as a JBTS-causing gene, and our functional 
studies suggest that KIF7 is closely linked to the biology of cilia, 
centrosomes, and the Golgi network by regulating the stability 
and dynamics of microtubules.
Results and Discussion
Mapping of a locus for Joubert syndrome, JBTS12, to chromosome 15q. In 
a consanguineous Egyptian family with 2 JBTS individuals, desig-
nated E1 and E2 (Figure 1, A and D), genome-wide linkage analysis 
revealed a 15.3-Mb region with homozygosity by descent on chro-
mosome 15q25.3–q26.3 (between SNPs rs717552 and rs352744). 
This locus for Joubert syndrome has been registered as JBTS12 
(HGNC accession code for KIF7 [alias JBTS12]: 30497) and con-
tained approximately 85 genes, and candidates were prioritized by 
expression pattern and/or structure. No mutations were found in 
TTC23, NTRK3, and RLBP1. We then focused on KIF7, an essential 
regulator of Shh signaling localized in cilia. Notably, the JBTS pro-
teins ARL13B and RPGRIP1L are implicated in Shh signaling (4, 5). 
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Figure 1
KIF7 mutations cause Joubert syndrome and define a novel disease locus, JBTS12. For clarity, the one-letter code was applied for mutation 
designation. (A–C) Pedigrees of JBTS families with KIF7 mutations. (A) Egyptian index family. Linkage analysis in this family identified the 15q 
locus harboring KIF7. (B) G1 family. Abortion was induced in the first pregnancy because of an encephalocele. (C) G2 family. (D) Top: Axial 
brain MRIs showing molar tooth sign (red arrow) from the affected members of each family. Bottom: Dysmorphic features characteristic of JBTS 
(pronounced in E1 and E2, with hexadactyly in E1 and hypertelorism in G1). No dysmorphism in G2. (E) KIF7 gene structure (drawn to scale), 
mutations, and protein illustration. (F) Expression profile of human and mouse KIF7 (RT-PCR).
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Loss of Kif7 function in mice results in polydactyly, exencephaly, 
skeletal defects, and early lethality (6–8), symptoms reminiscent 
of both Hedgehog pathway mutants and JBTS mouse models, e.g., 
Inpp5e–/– mice (9). RT-PCR revealed widespread expression of KIF7 
(Figure 1F) and, consistent with RNA in situ hybridization data 
(available at Allen Mouse Brain Atlas, http://mouse.brain-map.
org), strong expression in the cerebellum.
Mutations of KIF7 cause JBTS. We identified a homozygous 1-bp 
deletion in exon 1 of KIF7 (c.217delG) that segregates with the 
phenotype and results in either a heavily truncated protein 
(p.A73PfsX109) or nonsense-mediated decay. We extended the 
DNA analysis to 63 additional JBTS patients. A German girl 
(G1) carried a heterozygous 12-bp deletion in the last KIF7 exon 
(c.3986_3997del12; Figure 1, B and D), predicting a likely deleteri-
ous in-frame loss of 4 residues in the putative KIF7 cargo domain 
(Figure 1E). A male German patient (G2) carried a heterozygous 
truncating deletion in KIF7 exon 3 (c.811delG; Figure 1C and Sup-
plemental Figure 1; supplemental material available online with 
this article; doi:10.1172/JCI43639DS1). As no further KIF7 muta-
tions were detected by direct sequencing in patients G1 and G2, 
we performed array comparative genomic hybridization (CGH) on 
a NimbleGen array with probes densely covering the KIF7 locus, 
as well as genome-wide CGH (Affymetrix 6.0 SNP array). Neither 
patient showed structural alterations adjacent to or within KIF7 
(Supplemental Figure 2), or the relatively frequent NPHP1 deletion 
(10). Sequencing of all known autosomal JBTS genes revealed 2 
TMEM67 mutations, p.P358L and p.I833T, in patient G1, but 
no mutations in G2. The most severe phenotype was observed 
in patients E1 and E2 with biallelic loss of KIF7. In G1, mental 
retardation and facial dysmorphism were less pronounced. The 2 
hypomorphic TMEM67 mutations have frequently been found in 
patients with COACH (JBTS with coloboma and hepatic fibrosis), 
but never in combination (11, 12). Disease in G1 may result from 
the mutational load, with 3 mutant alleles in 2 JBTS genes, similar 
to what has been shown for patients with a distinct ciliopathy, Bar-
det-Biedl syndrome (13). In G2, either a mutation in a functionally 
related gene not yet implicated in JBTS or a second KIF7 mutation 
that escaped detection due to its localization (e.g., deep intronic or 
in a regulatory region outside the coding sequence) is likely. The 
phenotype of G2 is relatively mild, with moderate developmental 
delay and no dysmorphic signs (Table 1).
Defects of cilia formation and centrosome duplication and fragmentation 
of the Golgi network in KIF7-deficient cells. To address the pathophysio-
logic mechanisms of KIF7 deficiency, we transfected siRNA direct-
ed against the 3′-untranslated region (3′-UTR) of KIF7 mRNA in 
polarized retinal epithelial cells (Supplemental Figure 3) and 
assayed for the cellular phenotype. KIF7-deficient cells displayed a 
dispersed staining pattern of the Golgi apparatus (Figure 2A, Sup-
plemental Figures 4 and 6), a phenotype that had been previously 
observed in cells deficient for the kinesin-2 subunits KAP3 and 
KIF3A (14). Transfection of the KIF7 coding sequence into knock-
down cells was able to rescue this phenotype, whereas expression 
of a protein lacking the predicted motor domain (KIF7513–1343) did 
not (Supplemental Figure 5), indicating that the knockdown phe-
notype was the result of defective KIF7 motor activity. Strikingly, 
expression of the latter truncation also induced a dispersed Golgi 
staining pattern similar to the one observed in knockdown cells, 
suggesting a crucial role of the predicted KIF7 motor domain for 
maintaining Golgi structure (Supplemental Figure 5). Electron 
microscopy confirmed disruption of regular Golgi patterning in 
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KIF7 siRNA–treated cells (Figure 2B); however, a marked gener-
al Golgi transport defect could not be demonstrated, as labeled 
VSV-G protein did not show apparent deficiencies in membrane 
delivery (not shown). Golgi dispersal was also observed with 
siRNAs directed against the protein-coding sequence of KIF7 (Sup-
plemental Figures 7 and 8). In addition to the dramatic changes in 
Golgi structure, we observed more subtle defects such as abnormal 
centrosome duplications and a reduced number of ciliated cells 
(Figure 2, C and D), reminiscent of previously reported findings 
in other JBTS proteins (15).
KIF7 interacts with the JBTS4 protein NPHP1. Since several human 
ciliopathy proteins function in multiprotein complexes to regu-
late cilia formation, microtubule dynamics, or Golgi structure, 
we tested whether KIF7 interacted with known JBTS proteins. 
Intriguingly, KIF7 specifically co-precipitated with nephrocystin-1 
(NPHP1) and vice versa (Supplemental Figure 9). Mapping of the 
interaction revealed that amino acids 513–775 of KIF7 were suf-
ficient for co-precipitation of NPHP1 (Supplemental Figure 9). 
Immunofluorescence stainings of NPHP1 in KIF7-knockdown 
cells showed a redistribution of NPHP1 as a result of the Golgi 
phenotype (Supplemental Figure 10). The JBTS1 protein INPP5E 
also localizes to the Golgi apparatus (16). However, in contrast to 
INPP5E, KIF7 did not influence PDGF-induced phosphorylation 
of AKT (Supplemental Figure 11), pointing to potentially diver-
gent molecular mechanisms of disease. Taken together, these data 
suggest that KIF7 either acts through directly regulating Golgi 
morphology and function or that the Golgi phenotype results 
from a cellular defect of membrane fusion, vesicle targeting, or 
cytoskeletal regulation.
KIF7 affects microtubular dynamics. We have previously shown 
that ciliopathy disease proteins may associate with or act through 
microtubule regulatory proteins (17). Since defects in microtubu-
lar dynamics can result in Golgi disruption (18), defects in cilio-
genesis (19), and altered cell morphology, we reasoned that the 
KIF7 phenotype may be the result of altered microtubular dynam-
ics. Interestingly, expression of KIF7513–1343 as well as knockdown 
of KIF7 led to a marked stabilization of acetylated microtubules on 
ice (Figure 3A and Supplemental Figure 12A). The histone deacety-
lase HDAC6 has recently been linked to the regulation of cytoplas-
mic microtubule acetylation by the Bardet-Biedl syndrome protein 
BBIP10 (19). Strikingly, HDAC6 specifically co-precipitated with 
KIF7 (Supplemental Figure 12B), and expression of KIF7513–1343 led 
to an increase in acetylated tubulin in HEK293T cells (Supplemen-
tal Figure 12C). These data indicated that KIF7 is involved in the 
regulation of microtubule acetylation and stabilization. Because 
stabilization of microtubule and lack of the microtubule dynam-
ics have been shown to induce Golgi dispersal (20), microtubule 
overstability likely explains the cellular KIF7 phenotypes observed 
in our study. Moreover, we demonstrate maloriented microtubular 
growth after KIF7 knockdown in microtubular re-polymerization 
Figure 2
KIF7 is required for Golgi, centrosomal, and ciliary integrity. siRNA knockdown results in dispersal of the Golgi apparatus as seen in (A) 
immunofluorescence stainings for golgin-97 and (B) electron microscopy (arrows indicate Golgi fields; co, control; Nu, nucleus). While Golgi 
stacks in control cells are mainly found in the perinuclear region, Golgi-derived vesicles and enlarged Golgi fields are widely distributed between 
the nucleus and the apical membrane in knockdown cells. (C) Moreover, KIF7 knockdown cells show abnormal centrosomal duplication and (D) 
a reduced number of cilia. Scale bars: 10 μm (A, C, and D); 5 μm (B). *P < 0.05 in an unpaired Student’s t test.
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Besides, KIF7 represents a prime candidate for mono- and oligo-
genic forms of related ciliopathies, namely Meckel-Gruber, Senior 
Loken, and Bardet-Biedl syndromes, Leber congenital amaurosis, 
and nephronophthisis.
Methods
Patients. The study was approved by the review boards of the Ethics Com-
mittees of the University Hospitals of Cologne, Schleswig-Holstein, and 
Zurich. Biological samples were donated by the patients after their par-
ents provided written informed consent in accordance with the Declara-
tion of Helsinki. The patients’ parents gave written consent for display-
ing the photo images.
assays (Figure 3B), and we noticed differences in the shape of cells 
treated with KIF7 siRNA (Figure 3C). When looking for potential 
KIF7-interacting regulators of directed microtubular growth, we 
found PAR3 to be associated with KIF7 (Figure 3D).
KIF7 has recently been shown to be a key regulator of vertebrate 
Shh signaling that localizes to the ciliary base and translocates to 
the ciliary tip upon pathway activation by ligand binding (8). Our 
findings link KIF7 with Golgi morphology, centrosomal dupli-
cation, ciliogenesis, and Hedgehog signaling. We propose modi-
fied microtubule stability and growth direction caused by loss of 
KIF7 function as the underlying disease mechanism impacting 
all these structures and processes, ultimately resulting in JBTS. 
Figure 3
KIF7 dysfunction affects microtubular stability and dynamics. (A) In hTERT-RPE1 cells expressing KIF7513–1343, acetylated microtubules are 
resistant to de-polymerization on ice. (B) Re-polymerization of microtubules in KIF7 knockdown cells is less coordinated. (C) KIF7 knockdown 
cells display changes in the cell shape. (D) KIF7 interacts with the polarity protein PAR3. PAR3 is specifically able to precipitate KIF7. Scale 
bars: 20 μm (A and C); 10 μm (B).
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Genetic linkage analysis. See Supplemental Methods for details.
Mutation analyses. See Supplemental Methods for details.
Exclusion of large deletions and duplications involving KIF7 and NPHP1 in patients 
G1 and G2. The Affymetrix genome-wide Human SNP Array 6.0 utilizing 
more than 906,600 SNPs and more than 946,000 copy number probes was 
used for genome-wide detection of copy number variations. Quantitative data 
analyses were performed with GTC 3.0.1 (Affymetrix Genotyping Console) 
using HapMap270 (Affymetrix) as reference file. In addition, to detect and 
fine map potential deletions and/or duplications within KIF7, we performed 
oligonucleotide microarray CGH analysis. This analysis was carried out with a 
custom-designed high-resolution 385K array (Roche NimbleGen) with oligo-
nucleotide probes (50mers to 75mers, spacing of approximately 20 bp).
Expression analysis. See Supplemental Methods for details.
Plasmids. The full-length coding sequence of KIF7 was cloned by stan-
dard techniques using I.M.A.G.E. cDNA clones (BC042063, BC112271) 
and gene synthesis for bp c.1,188–1,553 (GenScript). The HDAC6 coding 
sequence was PCR amplified from a human fetal brain library (Strata-
gene). The NPHP1, gfp, Par3, Par6, and aPKC plasmids have previously 
been described (17).
Antibodies, cell culture, and transfections. See Supplemental Methods for 
details.
RNAi experiments. KIF7 and control siRNAs were purchased from 
Biomers or Ambion (Life Technologies) and had the following sequences: 
5′-UUGUUGAUCCCAGUGAGGGUATT-3′ and 5′-UACCCUCACUG-
GGAUCAACAATT-3′ (siRNA#1, 3′-UTR), 5′-GCAAGUAUUUUGA-
CAAGGUTT-3′ and 5′-ACCUUGUCAAAAUACUUGCAG-3′ (siRNA#2, 
coding sequence), and 5′-GUGACACGUUCGGAGAATTAC-3′ and 
5′-AATTCTCCGAACGUGUCACGU-3′ (control siRNA).
Quantitative PCR. See Supplemental Methods for details.
Immunoprecipitation. Immunoprecipitations were performed as previ-
ously described (17). Experiments were repeated at least 3 times with 
identical results.
Immunofluorescence staining of hTERT-RPE1 cells. hTERT-RPE1 cells 
were seeded on glass slides, immunostained by standard techniques, 
and subjected to immunofluorescence microscopy (Axiovert 200 with 
ApoTome System, Zeiss).
De- and re-polymerization of microtubules. For de-polymerization, hTERT-
RPE1 cells were incubated on ice for 30 minutes. Re-polymerization 
of microtubules was initialized by addition of prewarmed medium and 
stopped by fixation at the indicated time points.
Quantification of centrosomal duplication and cilia numbers. See Supplemental 
Methods for details.
Dual luciferase assay and electron microscopy. See Supplemental Methods 
for details.
Statistics. Data are expressed as mean ± SEM of n experiments. Statisti-
cal evaluation was performed by using 2-tailed Student’s t test. P values 
less than 0.05 were considered significant.
URLs. To predict the putative functional impact of the in-frame deletion 
in patient G1, we used MutationTaster, http://neurocore.charite.de/Muta-
tionTaster/. ScanProsite (http://www.expasy.ch/tools/scanprosite) was 
used for prediction of KIF7 protein domains. Description of KIF7 RNA 
in situ data relate to the corresponding entry in Allen Brain Atlas, http://
mouse.brain-map.org.
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